acebutolol has been researched along with cyclosporine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thakker, DR; Troutman, MD | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benchimol, D; Bennani, Y; Bourgeon, A; Cordero, C; Delmont, J; Delque-Bayer, P; Giudicelli, J; Pesce, A; Pulcini, A; Saint-Paul, MC | 1 |
| Chen, HF; Daloze, P; Kahan, BD; Stepkowski, SM; Wang, ME | 1 |
| Atkinson, JB; Ford, EG; Kitagawa, H; Sinatra, F; Thomas, D | 1 |
| Wemmer, DE; Williams, PG | 1 |
| Bakonyi Neto, A; Garcez-Silva, MH; Goldenberg, S; Koh, IH | 1 |
| Greenstein, SM; Kim, DY; Schechner, RS; Schreiber, TC; Sun, S; Tellis, VA | 1 |
| Bugli, F; Butler, R; Cioli, D; Khattab, A; Klinkert, MQ; Vigneti, E | 1 |
| Fukaya, H; Fuyumuro, T; Hoshiko, K; Iimura, A; Nabeshima, T; Noji, S | 1 |
2 review(s) available for acebutolol and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Use of nuclear magnetic resonance in probing ligand-macromolecule interactions.
Topics: Amino Acid Isomerases; Binding Sites; Carrier Proteins; Cyclosporine; Distamycins; DNA; In Vitro Techniques; Kinetics; Ligands; Macromolecular Substances; Magnetic Resonance Spectroscopy; Maltose; Maltose-Binding Proteins; Models, Molecular; Peptidylprolyl Isomerase; Protein Binding; Thermodynamics; Tritium | 1994 |
16 other study(ies) available for acebutolol and cyclosporine
| Article | Year |
|---|---|
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
[Segmental small intestine transplantation in dogs: comparison between a jejunal graft and an ileal graft].
Topics: Alkaline Phosphatase; Animals; Biopsy; Cyclosporine; Dogs; Graft Rejection; Ileum; Immunosuppression Therapy; Jejunum; Maltose; Transplantation, Autologous; Transplantation, Homologous; Xylose | 1992 |
Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Topics: Animals; Body Weight; Cyclosporine; Dose-Response Relationship, Drug; Graft Survival; Graft vs Host Reaction; Host vs Graft Reaction; Immunosuppressive Agents; Intestinal Absorption; Intestine, Small; Male; Maltose; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred BUF; Rats, Inbred Lew; Rats, Inbred WF; Sirolimus; Transplantation, Homologous | 1992 |
Fecal fat, cyclosporine, and alpha 1-antitrypsin for assessment of small bowel function following transplantation.
Topics: alpha 1-Antitrypsin; Animals; Cyclosporine; Dietary Fats; Fats; Feces; Intestinal Absorption; Intestine, Small; Male; Maltose; Rats; Rats, Inbred Lew | 1991 |
Validity of the maltose absorption test in the heterotopic small bowel transplant model.
Topics: Administration, Oral; Animals; Blood Glucose; Cyclosporine; Intestinal Absorption; Intestine, Small; Maltose; Muscle, Smooth; Predictive Value of Tests; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Heterotopic; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
Nifedipine protects small intestine from cyclosporine-induced hemodynamic and functional impairment.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Hemodynamics; Intestine, Small; Intestines; Maltose; Nifedipine; Rats; Rats, Inbred Lew; Regional Blood Flow; Vascular Resistance | 1997 |
Expression cloning and biochemical characterizations of recombinant cyclophilin proteins from Schistosoma mansoni.
Topics: Animals; Binding Sites; Blotting, Western; Cell Line; Cloning, Molecular; Cyclosporine; Enzyme Inhibitors; Histidine; Immune Sera; Maltose; Models, Molecular; Peptidylprolyl Isomerase; Protein Conformation; Rabbits; Recombinant Fusion Proteins; Schistosoma mansoni | 1998 |
A cyclosporin A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma.
Topics: Administration, Inhalation; Animals; Asthma; Cyclodextrins; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Male; Maltose; Mice; Mice, Inbred BALB C; Powders; Solubility | 2003 |